What is he best known for?
The fields of study he is best known for:
- Enzyme
- Biochemistry
- Amino acid
His scientific interests lie mostly in Amyloid, Biochemistry, Monomer, Oligomer and Protein oligomerization.
Gal Bitan interconnects Neurotoxicity, Neurodegeneration, Stereochemistry, Alzheimer's disease and In vivo in the investigation of issues within Amyloid.
His Neurodegeneration research includes elements of P3 peptide, Amyotrophic lateral sclerosis, Dementia and Neuroscience.
His work on Fibril as part of general Biochemistry research is often related to Extramural, thus linking different fields of science.
Gal Bitan focuses mostly in the field of Protein oligomerization, narrowing it down to matters related to Random hexamer and, in some cases, Circular dichroism.
His studies deal with areas such as Amyloid beta and Peptide as well as Biophysics.
His most cited work include:
- Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways (993 citations)
- Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease (651 citations)
- Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. (511 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Amyloid, Biochemistry, Biophysics, Stereochemistry and Peptide.
Gal Bitan combines subjects such as Neurotoxicity, P3 peptide, Neurodegeneration and In vivo with his study of Amyloid.
His Neurodegeneration research is multidisciplinary, relying on both Amyotrophic lateral sclerosis and Neuroscience.
Gal Bitan has researched Biochemistry in several fields, including Biochemistry of Alzheimer's disease and Toxicity.
His work on Fibril as part of general Biophysics research is frequently linked to Monomer, thereby connecting diverse disciplines of science.
The various areas that Gal Bitan examines in his Peptide study include Protein structure and C-terminus.
He most often published in these fields:
- Amyloid (43.33%)
- Biochemistry (32.67%)
- Biophysics (26.00%)
What were the highlights of his more recent work (between 2018-2021)?
- Biophysics (26.00%)
- Fibril (12.00%)
- In vitro (7.33%)
In recent papers he was focusing on the following fields of study:
Gal Bitan mainly focuses on Biophysics, Fibril, In vitro, Molecular tweezers and Amyloid.
His studies in Biophysics integrate themes in fields like Peptide, Tau protein, Peptide binding and Binding site.
His Fibril research incorporates elements of Extracellular and Intracellular.
His In vitro research focuses on In vivo and how it connects with Pharmacology, Amyotrophic lateral sclerosis, Microgliosis, Tauopathy and Presenilin.
The Molecular tweezers study combines topics in areas such as Viability assay, Neurotoxicity, Lead compound and Lysine.
The study incorporates disciplines such as Transthyretin, Endocrinology and Neurodegeneration in addition to Amyloid.
Between 2018 and 2021, his most popular works were:
- CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges (30 citations)
- Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation (21 citations)
- A Label-Free Platform for Identification of Exosomes from Different Sources. (21 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Biochemistry
- Amino acid
His primary areas of study are Synucleinopathies, Extracellular, Fibril, Computational biology and Microvesicles.
His work in Synucleinopathies addresses issues such as Atrophy, which are connected to fields such as Cancer research and Neuropathology.
He has included themes like Priming, Amyloid beta, Intracellular and Pathogenesis in his Extracellular study.
His research in Fibril intersects with topics in Long-term potentiation, In vitro, Kinase and Phosphorylation.
His Kinase research is multidisciplinary, incorporating perspectives in Biophysics, Tau protein and Binding site.
His Autophagy research spans across into areas like Amyloid and Neurodegeneration.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
